Thomas Stoker - Publications

Affiliations: 
Management Massachusetts Institute of Technology, Cambridge, MA, United States 

0/24 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
Low-probability matches (unlikely to be authored by this person)
2017 Stoker TB, Blair NF, Barker RA. Neural grafting for Parkinson's disease: challenges and prospects. Neural Regeneration Research. 12: 389-392. PMID 28469646 DOI: 10.4103/1673-5374.202935  0.198
2022 Drouin-Ouellet J, Legault EM, Nilsson F, Pircs K, Bouquety J, Petit F, Shrigley S, Birtele M, Pereira M, Storm P, Sharma Y, Bruzelius A, Vuono R, Kele M, Stoker TB, et al. Age-related pathological impairments in directly reprogrammed dopaminergic neurons derived from patients with idiopathic Parkinson's disease. Stem Cell Reports. PMID 36150382 DOI: 10.1016/j.stemcr.2022.08.010  0.194
2018 Stoker TB, Torsney KM, Barker RA. Emerging Treatment Approaches for Parkinson's Disease. Frontiers in Neuroscience. 12: 693. PMID 30349448 DOI: 10.3389/fnins.2018.00693  0.181
2021 Pircs K, Drouin-Ouellet J, Horváth V, Gil J, Rezeli M, Garza R, Grassi DA, Sharma Y, St-Amour I, Harris K, Jönsson ME, Johansson PA, Vuono R, Fazal SV, Stoker T, et al. Distinct subcellular autophagy impairments in induced neurons from Huntington's disease patients. Brain : a Journal of Neurology. PMID 34936701 DOI: 10.1093/brain/awab473  0.179
2018 Stoker TB, Barker RA. Regenerative Therapies for Parkinson's Disease: An Update. Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy. PMID 30027398 DOI: 10.1007/s40259-018-0294-1  0.178
2020 Stoker TB, Barker RA. Recent developments in the treatment of Parkinson's Disease. F1000research. 9. PMID 32789002 DOI: 10.12688/f1000research.25634.1  0.17
2016 Stoker TB, Barker RA. Cell therapies for Parkinson's disease: how far have we come? Regenerative Medicine. PMID 27885887 DOI: 10.2217/rme-2016-0102  0.167
2021 Stoker TB, Mason SL, Greenland JC, Holden ST, Santini H, Barker RA. Huntington's disease: diagnosis and management. Practical Neurology. PMID 34413240 DOI: 10.1136/practneurol-2021-003074  0.165
2020 Stoker TB, Camacho M, Winder-Rhodes S, Liu G, Scherzer CR, Foltynie T, Evans J, Breen DP, Barker RA, Williams-Gray CH. Impact of variants on long-term clinical progression and mortality in incident Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32303560 DOI: 10.1136/jnnp-2020-322857  0.146
2021 Stoker TB, Holden ST, Barker RA. Late-onset Huntington's disease associated with CAG repeat lengths of 30 and 31. Journal of Neurology. PMID 34142177 DOI: 10.1007/s00415-021-10633-3  0.137
2021 Bruzelius A, Kidnapillai S, Drouin-Ouellet J, Stoker T, Barker RA, Rylander Ottosson D. Reprogramming Human Adult Fibroblasts into GABAergic Interneurons. Cells. 10. PMID 34943958 DOI: 10.3390/cells10123450  0.134
2021 Stoker TB, Holden ST, Barker RA. Correction to: Late‑onset Huntington's disease associated with CAG repeat lengths of 30 and 31. Journal of Neurology. PMID 34191082 DOI: 10.1007/s00415-021-10691-7  0.133
2020 Stoker TB, Camacho M, Winder-Rhodes S, Liu G, Scherzer CR, Foltynie T, Barker RA, Williams-Gray CH. A common polymorphism in is associated with accelerated motor decline in -Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 32241921 DOI: 10.1136/jnnp-2019-322210  0.125
2020 Stoker TB, Andresen KER, Barker RA. Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's Disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 33125799 DOI: 10.1002/mds.28359  0.124
1990 Stoker T. Nonparametric test of additive derivative constraints Contributions to Economic Analysis. 195: 43-108. DOI: 10.1016/B978-0-444-88515-9.50010-7  0.102
2019 Birtele M, Sharma Y, Kidnapillai S, Lau S, Stoker T, Barker RA, Rylander Ottosson D, Drouin-Ouellet J, Parmar M. Dual modulation of neuron-specific microRNAs and the REST complex promotes functional maturation of human adult induced neurons. Febs Letters. PMID 31535361 DOI: 10.1002/1873-3468.13612  0.091
2023 Stoker TB. Bilateral hypertrophic olivary degeneration in symptomatic palatal tremor. Practical Neurology. PMID 36759175 DOI: 10.1136/pn-2022-003678  0.079
2022 Stoker TB, Dostal V, Cochius J, Williams-Gray CH, Scherzer CR, Wang J, Liu G, Coyle-Gilchrist I. DCTN1 mutation associated parkinsonism: case series of three new families with perry syndrome. Journal of Neurology. PMID 35895135 DOI: 10.1007/s00415-022-11308-3  0.075
2013 Stoker T, Young A, Massoud T, Patani R, Manford M. Primary Cerebral Lymphoma Causing Remitting and Relapsing Neurological Symptoms Journal of Medical Cases. 4: 420-423. DOI: 10.4021//Jmc.V4I6.1358  0.063
2021 Pandey A, Stoker T, Adamczyk LA, Stacpoole S. Aseptic meningitis and hydrocephalus secondary to neurosarcoidosis. Bmj Case Reports. 14. PMID 34446511 DOI: 10.1136/bcr-2021-242312  0.06
2012 Young AM, Stoker TB. Audio-induced psychogenic non-epileptic seizures. Scottish Medical Journal. 57: 60. PMID 22408222 DOI: 10.1258/smj.2011.011278  0.042
2012 Suri T, Jack W, Stoker TM. Documenting the birth of a financial economy. Proceedings of the National Academy of Sciences of the United States of America. 109: 10257-62. PMID 22689945 DOI: 10.1073/pnas.1115843109  0.039
2016 Stoker TB, Evans NR. Managing Risk After Intracerebral Hemorrhage in Concomitant Atrial Fibrillation and Cerebral Amyloid Angiopathy. Stroke; a Journal of Cerebral Circulation. PMID 27272484 DOI: 10.1161/STROKEAHA.116.013323  0.034
2016 Stoker TB, Evans NR, Warburton EA. Internal carotid artery dissection. British Journal of Hospital Medicine (London, England : 2005). 77: 708-711. PMID 27937023 DOI: 10.12968/hmed.2016.77.12.708  0.03
Hide low-probability matches.